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H I G H L I G H T S
 Statistical considerations on the US National Toxicology Program (NTP).
 The Technical Report TR 578 on Ginkgo biloba was selected as an example.
 It reports on 209 signiﬁcant tests, but >240 false signiﬁcant tests are expected.
 NTP delivers explorative tests, it generates hypotheses, but does not prove them.
 Only a conﬁrmative test is able to transform a hypothesis into proven evidence.
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A B S T R A C T
The US National Toxicology Program (NTP) is assessed by a statistician. In the NTP-program groups of
rodents are fed for a certain period of time with different doses of the substance that is being investigated.
Then the animals are sacriﬁced and all organs are examined pathologically. Such an investigation
facilitates many statistical tests. Technical Report TR 578 on Ginkgo biloba is used as an example. More
than 4800 statistical tests are possible with the investigations performed. Due to a thought experiment
we expect >240 false signiﬁcant tests. In actuality, 209 signiﬁcant pathological ﬁndings were reported.
The readers of Toxicology Letters should carefully distinguish between conﬁrmative and explorative
statistics. A conﬁrmative interpretation of a signiﬁcant test rejects the null-hypothesis and delivers
“statistical proof”. It is only allowed if (i) a precise hypothesis was established independently from the
data used for the test and (ii) the computed p-values are adjusted for multiple testing if more than one
test was performed. Otherwise an explorative interpretation generates a hypothesis. We conclude that
NTP-reports – including TR 578 on Ginkgo biloba – deliver explorative statistics, i.e. they generate
hypotheses, but do not prove them.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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This is the oldest and largest program on risk assessment.
Experiments are well-structured and highly standardized. Groups$ This is an open-access article distributed under the terms of the Creative
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permits non-commercial use, distribution, and reproduction in any medium,
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0378-4274/This is an open access article under the CC BY-NC-ND license (http://creatiof rodents are fed for a certain period of time with different doses
of the substance to be investigated (plus dose zero as a control).
Then the animals are sacriﬁced and all organs are examined
pathologically. The results of each dosing group are compared to
the control group and tested statistically if conspicuous.
Statistical considerations
I am statistician at a medical faculty. A toxicologist friend of
mine asked me how relevant the results of the NTP are from a
statistical epoint of view. Toxicologists and other people workingvecommons.org/licenses/by-nc-nd/3.0/).
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in my answer as well.
Multiple comparisons with the same control group
In NTP-studies, each group receiving a dose of active
substance is compared to the control group. By the way,
multiple use of the control group requires a speciﬁc statistical
methodology, e.g. the modiﬁcation of the t-test by Dunnett,
1964. But I do not want to follow this up in any further detail. I
want to estimate how many false signiﬁcant tests we have to
expect in an NTP report.
How many false signiﬁcant tests are to be expected?
Let us make a thought experiment to estimate the number of
false signiﬁcant statistical tests in a technical report (TR) of the
NTP. The often used level of signiﬁcance of 5% means that if
there is actually no effect in the data, then the probability of
getting a (false) signiﬁcant test result is 5%. Assume that in an
experiment, statistical tests are used to compute c comparisons
between groups for each of v variables. Furthermore, assume
that all data stem from a random number generator. Therefore,
all signiﬁcances found in this thought experiment are false.
Under these conditions and with the usual level of signiﬁcance
of 5% we expect for the c  v statistical tests c  v  0.05
signiﬁcant results. A reasonable researcher will not compute
all these tests, of course. First, he will look at the descriptive
statistical results and compute the test only for those
comparisons with a realistic chance of being signiﬁcant.
Nevertheless, he will ﬁnd all signiﬁcant results in the data.
The fact that tests without a chance of becoming signiﬁcant
were not computed to save superﬂuous workload still does not
reduce the number of signiﬁcant tests.
Example
In order to make the statistical considerations easier to
understand, let us take TR 578 on “Toxicology and carcinogenesis
studies of Ginkgo biloba extract in F344/N rats and B6C3F1/N mice”
as an example. This report covers a 3-month and a 2-year study in
rats, a 3-month and a 2-year study in mice, and 2 smaller studies on
clinical pathology. The 3-month studies had 5 dosing groups (62.5,
125, 250, 500, and 1000 mg) plus control, the 2-year studies had 3
dosing groups (100, 300, and 1000 mg for rats; 200, 600, and
2000 mg for mice) plus the control group. Each study was
performed for a group of female and a group of male animals.
How many statistical tests are possible in TR 578?
On page 6 we read: “At the end of the studies, tissues from more
than 40 sites were examined for every animal.” Findings were e.g.Table 1
Number of comparisons between groups investigated in NTP TR 578.
Duration Species Number of animals 
Study 1 3 months Rats 10 females + 10 males 
Study 2 23 days Rats 10 females + 10 males 
Study 3 3 months Mice 10 females + 10 males 
Study 4 2 years Rats 50 females + 50 males 
Study 5 3 months Rats 10 females + 10 males 
Study 6 2 years Mice 50 females + 50 males 
Each group with an active dose is compared to the control group. These comparisons “hypertrophy of the organ”, “hypertrophy of speciﬁc cells”, “cystic
degeneration”, “epihtelium ulcer”, “inﬂammation”, “pigmenta-
tion”, “eosinophilic focus”, “hyaline droplet”, etc. (summary on
page 11 of TR 578). The above-mentioned 8 ﬁndings are only
examples. Most ﬁndings are not possible in all sites. We think that
for the 40 sites on average at least 2–3 ﬁndings were possible.
Hence, the total number of investigated outcome variables is
40  >2.5 = >100. The variables “body weight” and “rufﬂed fur”
were not considered, because they were investigated weekly.
How many false signiﬁcant tests are expected for TR 578?
In TR 578 on Ginkgo biloba, 48 comparisons between groups
were made (Table 1) with >100 possible outcome variables.
Therefore 48  >100 = >4800 statistical tests are possible. If a level
of signiﬁcance of 5% was used for these tests, then we expect
>4800  0.05 = >240 signiﬁcant tests, if all data came from a
random number generator. But of course, TR 578 presents real
data.
How many signiﬁcant tests are reported in TR 578?
In total, 209 signiﬁcant pathological ﬁndings are reported in the
summary of TR 578 (pages 7–9). This is about the number we
would expect if all data were just random numbers. Hence, we
conclude that most of the reported signiﬁcant results could be type
I errors. A type I error denotes that a relationship is called
signiﬁcant but in fact does not exist.
Explorative versus conﬁrmative testing
Modern medical statistics distinguish strictly between explor-
ative and conﬁrmative testing. Conﬁrmative interpretation of a
signiﬁcant test rejects the null-hypothesis and delivers “statistical
proof” for the so called alternative of the null-hypothesis. This
conﬁrmative interpretation is only allowed if two premises are
fulﬁlled: (i) a precise hypothesis was established independently
from the data used for the test and (ii) if more than one test is
performed, then the computed p-values are adjusted for multiple
testing. In opposition, these two prerequisites are not necessary for
an explorative interpretation of a signiﬁcant test. But explorative
testing means a signiﬁcant test generates a hypothesis, but does
not prove it. The a priori formulated hypothesis of the Ginkgo biloba
investigation was very general, i.e. Ginkgo biloba promotes cancer.
It was without a detailed speciﬁcation of site and type of cancer.
Furthermore, many tests are performed in TR 578, but no
adjustment for multiple testing is mentioned.
Conclusion
Most NTP-reports – including TR 578 on Ginkgo biloba – deliver
explorative statistics, i.e. they generate hypotheses, but do notActive doses Number of comparisons
5) 2 genders  5 doses = 10
5) 2 genders  5 doses = 10
5) 2 genders  5 doses = 10
3) 2 genders  3 doses = 6
3) 2 genders  3 doses = 6
3) 2 genders  3 doses = 6
Total number of comparisons between groups = 48
are made for a group of female and a group of male animals.
404 W. Gaus / Toxicology Letters 229 (2014) 402–404prove them. However, with a precise and well-founded hypothesis
half the work is already done.
Warning
Not all signiﬁcant tests provide “statistical proof”. Some
signiﬁcant tests only generate a hypothesis which has to be
proved in a new study. We think that the NTP-reports – especially
TR 578 on Ginkgo biloba – deliver hypotheses, but not proofs.
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